2. Academic Validation
  3. YM-216391, a novel cytotoxic cyclic peptide from Streptomyces nobilis. I. fermentation, isolation and biological activities

YM-216391, a novel cytotoxic cyclic peptide from Streptomyces nobilis. I. fermentation, isolation and biological activities

  • J Antibiot (Tokyo). 2005 Jan;58(1):27-31. doi: 10.1038/ja.2005.2.
Kin-ya Sohda 1,  Koji Nagai,  Takao Yamori,  Ken-ichi Suzuki,  Akihiro Tanaka
Affiliations

Affiliation

  • 1 Institute for Drug Discovery Research, Yamanouchi Pharmaceutical Co, Ltd, Itabashi-ku, Tokyo 174-8511, Japan. souda@yamanouchi.co.jp
PMID: 15813177 DOI: 10.1038/ja.2005.2
Abstract

YM-216391, a novel cyclic peptide, was isolated from the cultured mycelium of Streptomyces nobilis JCM 4274. It was purified by solvent extraction, silica gel and ODS flash column chromatographies, followed by preparative HPLC. YM-216391 dose-dependently inhibited the growth of human cervical Cancer HeLa S3 cells with an IC50 value of 14nM. YM-216391 also showed potent cytotoxic activity against a human Cancer cell line panel.

Figures
Products
  • Cat. No.
    Product Name
    Description
    Target
    Research Area
  • HY-N5208
    Antitumor Cyclic Peptide